Table 4. Summary of indications for the Extended Evaluation (ExE, n (%))*.
Offered ExE (n=83) |
Completed ExE (n=22) |
|
---|---|---|
Indication for ExE | ||
Post Void Residual >250cc twice in one day | 3 (3) | 2 (9) |
Side effects too bothersome | 39 (43) | 9 (40) |
Symptoms did not improve | 32 (35) | 14 (64) |
Urinary Tract Infection | 1 (1) | 1 (5) |
Other** | 16 (19) | 0 (0) |
No reason*** | 1 (1) | 1 (5) |
May sum to greater than 100% as participants could have more than one reason for ExE
Other reasons included: physician recommendation, other health reason, participant circumstances, “wait and see” what happens upon medication discontinuation, and other
One woman had an ExE with her private physician without having a study indication for ExE